ANGEL RIVERS: Open Payments
NPI 1730605890 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,131 in 27 payments from 11 companies in 2025. Trend: 2023 $100 · 2024 $557 · 2025 $1,131
Food & beverage: $1,131
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 4 | $278 |
| Otsuka America Pharmaceutical, Inc. | 4 | $212 |
| Neurocrine BioSciences, Inc. | 6 | $150 |
| ABBVIE INC. | 4 | $138 |
| Braeburn Inc. | 1 | $122 |
| E.R. Squibb & Sons, L.L.C. | 2 | $113 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| Lundbeck LLC | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
Products named: LYBALVI, REXULTI, INGREZZA, VRAYLAR, BRIXADI, COBENFY, AUSTEDO XR, ABILIFY MAINTENA.
Industry payments across AZ — which companies pay providers there.
